Ligand–receptor pairs including CD99‐CD99 and ADGRE5‐CD55 were predominantly identified in interactions between CD8+ T cells and NK cells with malignant cells, while Tregs mainly crosstalk with tumour cells via the TIGIT–NECTIN2 interaction. Here, CD99 is linked to neoplasm.